Structural damage in diabetic nephropathy is associated with TNF-α system activity
Authors:
- Fernández- RealFRFernández- Real
- José ManuelJMJosé Manuel
- Joan VendrellJVJoan Vendrell
- Isabel GarcíaIGIsabel García
- Wifredo RicartWRWifredo Ricart
- Martí VallèsMVMartí Vallès
- 1 November 2011
- journal article
- research article
- Published by Springer Nature in Acta Diabetologica
- Vol. 49 (4) , 301-305
Abstract
In experimental animal studies, tumour necrosis factor-α (TNF-α) contributed to renal hypertrophy during diabetes, and antibodies against TNF-α have led to improved histological lesions in animals with nephrotoxicity and diabetic nephropathy. We aimed to evaluate TNF-α system activity in association with renal histology in patients with type 2 diabetes. This is a prospective, cross-sectional study of 22 patients with type 2 diabetes (16 men), 13 with microalbuminuria and 9 with normoalbuminuria. Plasma-soluble TNF-α receptor 1 and 2 (sTNFR1 and sTNFR2) concentrations were used as surrogates of TNF-α system activity. Glomerular filtration rate (GFR) was analysed using I125-Iodothalamine. Albumin excretion rate (AER) and a renal biopsy were performed in all subjects. AER did not associate significantly with mesangial expansion or interstitial fraction in these subjects (r < 0.12, P > 0.5). AER was also not associated with either sTNFR1 or sTNFR2 levels. However, after controlling for GFR, the correlation between AER and sTNFR1 became significant (r = 0.47, P = 0.03). sTNFR1 correlated with age (r = 0.65, P < 0.001), mesangial expansion (r = 0.59, P = 0.004) and interstitial fraction (r = 0.58, P = 0.005). After controlling for age, body mass index and blood pressure, the association of TNFR1 with mesangial expansion persisted significant. Circulating sTNFR2 concentrations were not significantly associated with histological changes. In summary, structural kidney damage in patients with type 2 diabetes is associated with TNF-α system activity and specifically with plasma sTNFR1 concentrations.Keywords
This publication has 24 references indexed in Scilit:
- Relationships between serum adiponectin and soluble TNF-α receptors and glucose and lipid oxidation in lean and obese subjectsActa Diabetologica, 2011
- Systemic and spinal administration of etanercept, a tumor necrosis factor alpha inhibitor, blocks tactile allodynia in diabetic miceActa Diabetologica, 2010
- The predictive value of TNF-α and IL-6 and the incidence of macrovascular complications in patients with type 2 diabetesActa Diabetologica, 2010
- Circulating dendritic cell number and intracellular TNF-α production in women with type 2 diabetesActa Diabetologica, 2010
- Reduced GFR and albuminuria in Chinese type 2 diabetes mellitus patients are both independently associated with activation of the TNF-α systemDiabetologia, 2008
- Urinary protein excretion and serum tumor necrosis factor in diabetic patients with advanced renal failure: Effects of pentoxifylline administrationAmerican Journal of Kidney Diseases, 1999
- Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance.Diabetes, 1998
- Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathyKidney International, 1991
- Production of tumor necrosis factor by rat mesangial cells in response to bacterial lipopolysaccharideKidney International, 1989
- Cachectin/TNF and IL-1 Induced by Glucose-Modified Proteins: Role in Normal Tissue RemodelingScience, 1988